Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.
The drugs – called cilostazol and isosorbide mononitrate – are already used to treat other conditions, such as heart disease and angina.
This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia.
A study involving more than 50 stroke patients found that patients tolerated the drugs, with no serious side effects, even when the drugs were given in full dose or in combination with other medicines.
Experts say the findings pave the way for larger studies to check if the treatments can prevent brain damage and reduce risk of stroke and vascular dementia.
Damage to small blood vessels in the brain is responsible for around a quarter of strokes. It is also a common cause of memory problems and dementia.
Around 400,000 people in the UK are affected but there are no specific treatments. Currently the only way to reduce risk of the disease is by controlling blood pressure and cholesterol, stopping smoking and managing symptoms of diabetes.
Promising early signs
A team led by the Universities of Edinburgh and Nottingham recruited 57 patients who had experienced a stroke caused by damaged small blood vessels, known as a lacunar stroke.
Patients took the two medicines either individually or in combination for up to nine weeks, in addition to usual treatments aimed at preventing further strokes.
They completed health questionnaires and had regular blood pressure checks, blood tests and brain scans.
The findings suggest the drugs are safe for use in stroke patients, taken alone or in combination, at least in the short term.
There were also signs that the treatments helped improve blood vessel function in the arms and brain, and may improve thinking skills, but the researchers stress that further studies are needed to test this. A larger study, called LACI-2, is already underway.
The study, published in EClinicalMedicine, was funded primarily by the Alzheimer’s Society, with support from the UK Stroke Association, British Heart Foundation, the European Union, National Institutes of Health Research, and NHS Research Scotland.
We are delighted that the results of this trial show promise for treating a common cause of stroke and the commonest cause of vascular dementia, since currently there are no effective treatments. Further trials are underway.
Professor Joanna Wardlaw Centre for Clinical Brain Sciences
There hasn’t been a new drug for dementia for 15 years, so finding evidence that these cheap existing drugs could prevent dementia after a stroke would be a huge breakthrough. It’s promising to see that these two drugs are safe to use and we’ll be excited to see the results of the next stage of testing in a couple of years, which will show whether these drugs can be an effective treatment.
Dr James PickettHead of Research at Alzheimer’s Society
The Latest on: Stroke and vascular dementia
[google_news title=”” keyword=”stroke and vascular dementia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stroke and vascular dementia
- Stroke, High BP Don't Mediate Pollution's Link to Dementiaon September 27, 2023 at 5:00 pm
For this study, the authors hypothesized vascular dysfunction (stroke and hypertension) may act as a mediator of the association of PM 2.5 with dementia, given the association of PM 2.5 with ...
- Vascular risk factors influence cognitive health differently in men and women with Alzheimer's diseaseon September 27, 2023 at 3:16 am
Researchers utilize imaging findings to elucidate how Alzheimer's dementia can present considerable variations depending on the sex of the individual.
- Vascular Conditions Offer No Clarity on Pollution-Dementia Linkon September 25, 2023 at 2:43 pm
According to the researchers, PM 2.5 has been associated with vascular conditions such as cardiovascular disease, which suggests a relationship between PM 2.5 and vascular conditions could explain an ...
- Do stroke and hypertension mediate associations between exposure to air pollutants and dementia?on September 25, 2023 at 3:49 am
Whether stroke or hypertension modifies or mediates the relationship between particulate matter exposure and dementia.
- What’s the Difference Between Vascular Dementia and Alzheimer’s Disease?on September 18, 2023 at 7:50 am
This accumulated damage causes vascular dementia. The damage due to stroke can lead to problems with memory, attention, and decision making. Alzheimer’s is the most common form of dementia, affecting ...
- Vascular dementia 'red flag' warning that happens as you sleep - and shouldn't be ignoredon September 14, 2023 at 9:02 am
"Sleep apnoea is linked to a greater risk of developing a range of problems, including stroke, TIA, Alzheimer's disease and vascular dementia .... Suffice to say that if you have sleep apnoea ...
- Vascular dementia 'red flag' warning that happens as you sleep - and shouldn't be ignoredon September 14, 2023 at 7:08 am
People are being warned of an important factor that has been linked to the development of vascular dementia that may take place while you sleep by TV doctor Mark Porter ...
- New cause of Alzheimer's, vascular dementiaon September 11, 2023 at 11:15 am
Researchers have discovered a new avenue of cell death in Alzheimer's disease and vascular ... due to acute stroke or chronic conditions such as hypertension and diabetes. "Dementia is a process ...
- Alastair Stewart praised for ‘eloquence’ as charity talks vascular dementia riskon September 10, 2023 at 9:54 am
Alzheimer’s Research UK has spoken about vascular dementia prevention, risks, symptoms and the impact of stroke. We don't want there to be a stigma about it, we want people to be supportive ...
- Vascular Dementiaon September 4, 2023 at 5:00 pm
Vascular dementia is the second most common form of ... and its onset is caused by a number of small strokes or sometimes, one large stroke preceded or followed by other smaller strokes.
via Bing News